COVID-19: Pharma companies slash Remdesivir injection prices after govt intervention ANI | Updated: Apr 17, 2021 20:58 IST
New Delhi [India], April 17 (ANI): Amid the shortage of the anti-viral drug Remdesivir in the wake of spike in COVID-19 infections in the country, seven major pharmaceutical companies have reduced the maximum retail price (MRP) of the drug on the intervention of the Union government.
The announcement comes days after the Central government held a meeting with all-existing manufacturers of the drug and other stakeholders in order to discuss steps taken to increase production and supply and reduce prices of Remdesivir.
In an office memorandum issued on Saturday, the Ministry of Chemicals and Fertilizers said, with reference to the ongoing efforts for enhancement of availability and affordability of Remdesivir injection. On the intervention of the government, the major manufacturers/marketers of Remdesivir injection ha
Updated Apr 16, 2021 | 07:25 IST
The Drugs Controller General of India has granted permission for restricted use in emergency situations to Sputnik-V vaccine. India COVID vaccination program (Representational photo) | Photo Credit: AP
New Delhi: Two days after India fast-tracked emergency use approval for eligible foreign-produced shots against COVID-19, the Indian Ambassador to Russia confirmed that the first consignment of Russia s coronavirus vaccine Sputnik V will be delivered to India in April. What we heard from companies is that by (the end of) this month, the first shipment will take place and the production will be (launched) there in May and slowly increase, Indian Ambassador Bala Venkatesh was quoted by the Russian news agency Sputnik as saying.
Maharshtra to face shortage of Remdesivir for next 2 to 3 days: Minister
State FDA Minister Rajendra Shingane said pharma companies manufacturing Remdesivir have stepped up production but it will take time for the new stock to reach market.
Share Via Email
| A+A A- By PTI
MUMBAI: Maharashtra will face a shortage of 12,000 to 15,000 Remdesivir injections, used to treat COVID-19 patients, for the next two to three days, state Food and Drug Administration (FDA) Minister Rajendra Shingane said on Friday.
He said pharma companies manufacturing Remdesivir have stepped up production but it will take time for the new stock to reach the market.
Sputnik V will be available in India in the current quarter, price discussions on: Dr Reddy s thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.